Impact Factor 4.848 | CiteScore 3.5
More on impact ›


Front. Oncol., 31 March 2021 |

Corrigendum: The Contrived Mutant p53 Oncogene – Beyond Loss of Functions

  • 1Division of Cellular and Molecular Research, National Cancer Centre Singapore, Humphrey Oei Institute of Cancer Research, Singapore
  • 2Cancer and Stem Cell Biology Program, Duke-NUS Graduate Medical School, Singapore
  • 3Institute of Molecular and Cellular Biology, Singapore
  • 4Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

A Corrigendum on
The Contrived Mutant p53 Oncogene – Beyond Loss of Functions

by Sabapathy, K. (2015). Front. Oncol. 5:276. doi: 10.3389/fonc.2015.00276

In the original article, we overlooked to acknowledge the funder National Research Foundation, Singapore, NRF-NRFI-2015-007 to Kanaga Sabapathy.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

Keywords: dominant-negative effect, gain-of-functions, mutant p53-addiction, oncogene, p53, tumor-suppressor

Citation: Sabapathy K (2021) Corrigendum: The Contrived Mutant p53 Oncogene – Beyond Loss of Functions. Front. Oncol. 11:665504. doi: 10.3389/fonc.2021.665504

Received: 08 February 2021; Accepted: 09 February 2021;
Published: 31 March 2021.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2021 Sabapathy. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Kanaga Sabapathy,